Evoke Pharma   Report issue

For profit Phase 3
Founded: San Diego CA United States (2007)
Status: No NME R&D (2007)

Organization Overview

First Clinical Trial
2009
NCT00845858
First Marketed Drug
2020
metoclopramide (reglan)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Evoke Pharma, Inc. | EVOKE PHARMA INC

Active Ingredients

Marketed Drugs (1)

metoclopramide (reglan) (2020)

Drugs in Phase 3 Trials (1)

metoclopramide (reglan) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Gastroparesis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 1